Related Experiment Video
Updated: Apr 10, 2026
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1
Yung-Sheng Chang1, Wei-Yu Chen2, Juan Juan Yin3
1Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Abstract:
Dysregulation of the EGFR signaling axis enhances bone metastases in many solid cancers. However, the relevant downstream effector signals in this axis are unclear. miR-1 was recently shown to function as a tumor suppressor in prostate cancer cells, where its expression correlated with reduced metastatic potential. In this study, we demonstrated a role for EGFR translocation in regulating transcription of miR-1-1, which directly targets expression of TWIST1. Consistent with these findings, we observed decreased miR-1 levels that correlated with enhanced expression of activated EGFR and TWIST1 in a cohort of human prostate cancer specimens and additional datasets. Our findings support a model in which nuclear EGFR acts as a transcriptional repressor to constrain the tumor-suppressive role of miR-1 and sustain oncogenic activation of TWIST1, thereby leading to accelerated bone metastasis.
Insights
Epidermal Growth Factor Receptor (EGFR) nuclear translocation suppresses tumor-suppressive microRNA-1 (miR-1) in prostate cancer. This promotes TWIST1 activation and accelerates bone metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis Research
Background:
- Dysregulation of the Epidermal Growth Factor Receptor (EGFR) signaling pathway is implicated in the progression of bone metastases across various solid tumors.
- The specific downstream signaling effectors within the EGFR axis that drive this metastatic process remain incompletely understood.
- MicroRNA-1 (miR-1) has emerged as a critical tumor suppressor in prostate cancer, with its reduced expression correlating with increased metastatic potential.
Purpose of the Study:
- To elucidate the role of EGFR translocation in the transcriptional regulation of miR-1-1.
- To investigate the direct targeting relationship between miR-1 and TWIST1 expression.
- To establish a mechanistic link between EGFR signaling, miR-1, TWIST1, and prostate cancer bone metastasis.
Main Methods:
- Investigated the impact of EGFR translocation on miR-1-1 gene transcription.
- Utilized bioinformatics and experimental approaches to confirm miR-1 as a direct regulator of TWIST1.
- Analyzed human prostate cancer specimens and public datasets to correlate miR-1, activated EGFR, and TWIST1 expression levels.
Main Results:
- Demonstrated that EGFR translocation directly regulates the transcription of miR-1-1.
- Confirmed that miR-1 directly targets and suppresses TWIST1 expression.
- Observed inverse correlations between miR-1 levels and activated EGFR/TWIST1 expression in clinical prostate cancer samples.
Conclusions:
- Nuclear EGFR functions as a transcriptional repressor of the tumor-suppressive miR-1.
- This repression by nuclear EGFR sustains the oncogenic activation of TWIST1.
- The EGFR-miR-1-TWIST1 axis represents a key pathway driving accelerated bone metastasis in prostate cancer.
Related Concept Videos
02:38Mitogens and the Cell Cycle
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:54Canonical Wnt Signaling Pathway
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...